Amneal Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 640.00 Cr
as on 03-01-2025
- Paid Up Capital ₹ 362.77 Cr
as on 03-01-2025
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 46.29 Cr
as on 03-01-2025
- Revenue 16.94%
(FY 2022)
- Profit 9.40%
(FY 2022)
- Ebitda 9.61%
(FY 2022)
- Net Worth 86.78%
(FY 2022)
- Total Assets 51.44%
(FY 2022)
About Amneal Pharmaceuticals
The Corporate was formerly known as Amneal Pharmaceuticals Company (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 640.00 Cr and a paid-up capital of Rs 362.77 Cr.
The company has closed loans amounting to ₹46.29 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Amneal Pharmaceuticals Private Limited India is Ekta Joshi as COMPANY SECRETARY. Suresh Patel, Kanubhai Patel, Sandeep Raktate, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ2006PTC048109
- Company No.
048109
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Amneal Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ekta Joshi  | Company Secretary | 18-Nov-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandeep Raktate | Director | 14-May-2024 | Current |
| Rajeev Midha | Director | 25-Jan-2019 | Current |
| Suresh Patel | Whole-Time Director | 07-Apr-2006 | Current |
Kanubhai Patel  | Director | 17-Nov-2007 | Current |
| Rahul Maitra | Director | 14-May-2024 | Current |
Financial Performance of Amneal Pharmaceuticals.
Amneal Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.94% increase. The company also saw a slight improvement in profitability, with a 9.4% increase in profit. The company's net worth Soared by an impressive increase of 86.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amneal Pharmaceuticals?
In 2021, Amneal Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raks Pharma Private LimitedActive 16 years 2 monthsSuresh Patel, Sandeep Raktate and 2 more are mutual person
Amneal Oncology Private LimitedActive 26 years 2 monthsSuresh Patel, Rajeev Midha and 1 more are mutual person
Amneal Healthcare Private LimitedActive 3 years 7 monthsSuresh Patel, Sandeep Raktate and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 11 Dec 2012 | ₹0.80 M | Satisfied |
Bank Of Baroda Creation Date: 18 Jun 2012 | ₹0.83 M | Satisfied |
Bank Of Baroda Creation Date: 02 Mar 2012 | ₹1.52 M | Satisfied |
How Many Employees Work at Amneal Pharmaceuticals?
Amneal Pharmaceuticals has a workforce of 3948 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amneal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amneal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
